Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection

Exclusion Criteria

• •Hospitalized or impending hospitalization at the time of screening
• •Symptoms of cough, fever or shortness of breath within 72 hours
• •Prior or current treatment with other experimental or approved agents targeting SARS-CoV-2 or SARS-CoV-1
• •Positive pregnancy test
• •Active autoimmune disease or sarcoidosis (with the exception of controlled thyroid disease)
• •Active decompensated liver disease (ascites, encephalopathy)
• •Active congestive heart failure